aluates Reports

$ 0.0

Automative

Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-10U6000

Global HER2 Human Epidermal Growth Factor Receptor 2 Inhibitors Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Research Report 2025

Code: QYRE-Auto-10U6000

Report

June 2025

Pages:62

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

F Hoffmann La Roche Ltd

Merck& Co. Inc

Novartis

Pfizer Inc

Puma Biotechnology Inc

HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market

The global market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

HER2 regulates cell growth, survival and differentiation through a variety of signal transduction pathways.Several cancers, including breast, stomach and ovarian, are on the rise because of overexpression of HER2, which is inhibited by HER2 inhibitors

North American market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors in Breast Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors include F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Novartis AG, Pfizer Inc, Puma Biotechnology, Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors.

The HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Report

Report Metric	Details
Report Name	HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market
Segment by Type	Monotherapy Combination Therapy
Segment by Application	Breast Cancer Gastric Cancer Ovarian Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Novartis AG, Pfizer Inc, Puma Biotechnology, Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market report?

Ans: The main players in the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market are F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Novartis AG, Pfizer Inc, Puma Biotechnology, Inc

What are the Application segmentation covered in the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market report?

Ans: The Applications covered in the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market report are Breast Cancer, Gastric Cancer, Ovarian Cancer, Others

What are the Type segmentation covered in the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market report?

Ans: The Types covered in the HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market report are Monotherapy, Combination Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Monotherapy

1.2.3 Combination Therapy

1.3 Market by Application

1.3.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Breast Cancer

1.3.3 Gastric Cancer

1.3.4 Ovarian Cancer

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Perspective (2020-2031)

2.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Growth Trends by Region

2.2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Region (2020-2025)

2.2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Region (2026-2031)

2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Dynamics

2.3.1 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Industry Trends

2.3.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers

2.3.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges

2.3.4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Revenue

3.1.1 Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Revenue (2020-2025)

3.1.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Players (2020-2025)

3.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue

3.4 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio

3.4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2024

3.5 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Head office and Area Served

3.6 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Product and Application

3.7 Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Type

4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Type (2020-2025)

4.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2026-2031)

5 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Application

5.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Application (2020-2025)

5.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)

6.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)

6.4 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)

7.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)

7.4 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)

8.2 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2020-2025)

8.4 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)

9.2 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)

9.4 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2020-2031)

10.2 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025)

10.4 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 F. Hoffmann-La Roche Ltd

11.1.1 F. Hoffmann-La Roche Ltd Company Details

11.1.2 F. Hoffmann-La Roche Ltd Business Overview

11.1.3 F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction

11.1.4 F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)

11.1.5 F. Hoffmann-La Roche Ltd Recent Development

11.2 Merck & Co., Inc

11.2.1 Merck & Co., Inc Company Details

11.2.2 Merck & Co., Inc Business Overview

11.2.3 Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction

11.2.4 Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)

11.2.5 Merck & Co., Inc Recent Development

11.3 Novartis AG

11.3.1 Novartis AG Company Details

11.3.2 Novartis AG Business Overview

11.3.3 Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction

11.3.4 Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)

11.3.5 Novartis AG Recent Development

11.4 Pfizer Inc

11.4.1 Pfizer Inc Company Details

11.4.2 Pfizer Inc Business Overview

11.4.3 Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction

11.4.4 Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)

11.4.5 Pfizer Inc Recent Development

11.5 Puma Biotechnology, Inc

11.5.1 Puma Biotechnology, Inc Company Details

11.5.2 Puma Biotechnology, Inc Business Overview

11.5.3 Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction

11.5.4 Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)

11.5.5 Puma Biotechnology, Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

F Hoffmann La Roche Ltd

Merck& Co. Inc

Novartis

Pfizer Inc

Puma Biotechnology Inc

List of Tables

Table 1. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Monotherapy

Table 3. Key Players of Combination Therapy

Table 4. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2020-2025)

Table 8. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2026-2031)

Table 10. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Trends

Table 11. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers

Table 12. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges

Table 13. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints

Table 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Players (2020-2025)

Table 16. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2024)

Table 17. Ranking of Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Headquarters and Area Served

Table 20. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Product and Application

Table 21. Global Key Players of HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2020-2025)

Table 25. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2026-2031)

Table 27. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Application (2020-2025)

Table 29. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Application (2026-2031)

Table 31. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2026-2031) & (US$ Million)

Table 46. F. Hoffmann-La Roche Ltd Company Details

Table 47. F. Hoffmann-La Roche Ltd Business Overview

Table 48. F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product

Table 49. F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)

Table 50. F. Hoffmann-La Roche Ltd Recent Development

Table 51. Merck & Co., Inc Company Details

Table 52. Merck & Co., Inc Business Overview

Table 53. Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product

Table 54. Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)

Table 55. Merck & Co., Inc Recent Development

Table 56. Novartis AG Company Details

Table 57. Novartis AG Business Overview

Table 58. Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product

Table 59. Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)

Table 60. Novartis AG Recent Development

Table 61. Pfizer Inc Company Details

Table 62. Pfizer Inc Business Overview

Table 63. Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product

Table 64. Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)

Table 65. Pfizer Inc Recent Development

Table 66. Puma Biotechnology, Inc Company Details

Table 67. Puma Biotechnology, Inc Business Overview

Table 68. Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product

Table 69. Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025) & (US$ Million)

Table 70. Puma Biotechnology, Inc Recent Development

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

Table 74. Authors List of This Report

List of Figures

Figure 1. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Picture

Figure 2. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type: 2024 VS 2031

Figure 4. Monotherapy Features

Figure 5. Combination Therapy Features

Figure 6. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application: 2024 VS 2031

Figure 8. Breast Cancer Case Studies

Figure 9. Gastric Cancer Case Studies

Figure 10. Ovarian Cancer Case Studies

Figure 11. Others Case Studies

Figure 12. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Report Years Considered

Figure 13. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region: 2024 VS 2031

Figure 16. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Players in 2024

Figure 17. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2024

Figure 19. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)

Figure 21. United States HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)

Figure 25. Germany HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2020-2031)

Figure 33. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)

Figure 41. Mexico HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2020-2031)

Figure 45. Turkey HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. F. Hoffmann-La Roche Ltd Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)

Figure 49. Merck & Co., Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)

Figure 50. Novartis AG Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)

Figure 51. Pfizer Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)

Figure 52. Puma Biotechnology, Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2020-2025)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anti HER2 Therapy Market Research Report 2025

Global HER2 Positive Breast Cancer Market Research Report 2024

Global HR HER2 Breast Cancer Market Research Report 2024

Global HER2 Human Epidermal Growth Factor Receptor 2 Antibody Market Research Report 2024

Global HER2 Target Drugs Market Research Report 2024

Global Targeted Drug HER2 Inhibitors for NSCLC Market Research Report 2024

Global HER2 Antibody Market Research Report 2025

Global Epidermal Growth Factor Receptor EGFR Inhibitor Market Insights Forecast to 2030

Global HER 2 Targeted Drugs for Breast Cancer Market Research Report 2024

Global HER2 Targeted Therapy Market Research Report 2024

Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for HR HER2 Advanced Breast Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

HER 2 Negative Breast Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Therapy for Breast Cancer Market Research Report 2025

Global Epidermal Growth Factor Receptor Inhibitors Market Research Report 2024

Global Kinase Inhibitors Market Insights Forecast to 2030

Global Cancer Janus Kinase Inhibitors Market Research Report 2024

Global Herceptin Trastuzumab Market Research Report 2024

Global Breast Cancer Targeted Drug Market Research Report 2025

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4H16852

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K16619

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30U16301

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2G16953

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions